FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773875006: Antiemetic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726850010 Antiemetic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3726851014 Antiemetic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antiemetic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing dronabinol in oral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing granisetron in parenteral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing granisetron in oral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing granisetron Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Rolapitant Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only granisetron in oral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only granisetron in parenteral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only granisetron in transdermal dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only rolapitant in oral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only rolapitant in parenteral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Granisetron Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 each conventional release oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely granisetron (as granisetron hydrochloride) 2 milligram/1 each conventional release oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing rolapitant Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing rolapitant in oral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing rolapitant in parenteral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing granisetron in transdermal dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely granisetron (as granisetron hydrochloride) 200 microgram/1 milliliter conventional release oral solution Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely scopolamine butylbromide 10 milligram/1 each conventional release oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only scopolamine in oral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only scopolamine in parenteral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only scopolamine in transdermal dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely scopolamine butylbromide 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely scopolamine hydrobromide 600 microgram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely scopolamine hydrobromide 400 microgram/1 each conventional release oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely scopolamine 13.889 microgram/1 hour prolonged-release transdermal patch Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing ondansetron in oropharyngeal dose form (medicinal product form) Plays role False Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing ondansetron Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing ondansetron in oral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing ondansetron in parenteral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing ondansetron in rectal dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Palonosetron Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only netupitant and palonosetron in oral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only ondansetron in oral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only ondansetron in oromucosal dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only ondansetron in parenteral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only ondansetron in rectal dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only palonosetron in parenteral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing fosnetupitant and palonosetron (medicinal product) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only fosnetupitant and palonosetron (medicinal product) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing fosnetupitant and palonosetron in oral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing fosnetupitant and palonosetron in parenteral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only fosnetupitant and palonosetron in oral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only fosnetupitant and palonosetron in parenteral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ondansetron (as ondansetron hydrochloride) 2 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely palonosetron (as palonosetron hydrochloride) 50 microgram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Netupitant + Palonosetron Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Ondansetron Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release orodispersible film (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible film (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ondansetron 16 milligram/1 each conventional release rectal suppository Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ondansetron hydrochloride 24 milligram/1 each conventional release oral tablet Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing palonosetron Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing netupitant and palonosetron Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing netupitant and palonosetron in oral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ondansetron (as ondansetron hydrochloride) 800 microgram/1 milliliter conventional release oral solution Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing ondansetron in oromucosal dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing palonosetron in parenteral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Cinnarizine Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only amisulpride in parenteral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing amisulpride in parenteral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cinnarizine 25 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely aprepitant 40 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing nabilone Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nabilone 1 milligram/1 each conventional release oral capsule Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing only nabilone in oral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Nabilone Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nabilone 2 milligram/1 each conventional release oral capsule Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nabilone 500 microgram/1 each conventional release oral capsule Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nabilone 250 microgram/1 each conventional release oral capsule Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing nabilone in oral dose form (medicinal product form) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dexamethasone phosphate (as dexamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ondansetron 4 milligram/1 each conventional release oral lyophilisate (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ondansetron 8 milligram/1 each conventional release oral lyophilisate (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely aprepitant 125 milligram/1 sachet powder for conventional release oral suspension (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely aprepitant 165 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fosaprepitant (as fosaprepitant dimeglumine) 150 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fosaprepitant (as fosaprepitant dimeglumine) 115 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fosaprepitant (as fosaprepitant dimeglumine) 115 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ondansetron (as ondansetron hydrochloride) 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Ondansetron 8mg/5ml oral solution sugar free Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Tropisetron 5mg capsules Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Fosaprepitant 150mg powder for solution for infusion vials Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible films sugar free Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Ondansetron 4mg/2ml solution for injection ampoules Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Tropisetron 2mg/2ml solution for injection ampoules Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Ondansetron 4mg/5ml oral solution Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Granisetron 200micrograms/ml oral solution sugar free Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Tropisetron 5mg capsules Plays role False Antiemetic therapeutic role Inferred relationship Existential restriction modifier
Aprepitant 30mg/5ml oral suspension Plays role True Antiemetic therapeutic role Inferred relationship Existential restriction modifier

Start Page 2 of 3 End

This concept is not in any reference sets

Back to Start